Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24331154

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2014 Jan
First author
Butts C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Jan;15(1):5-6. doi: 10.1016/S1470-2045(13)70572-2.
    note
    Source null
    related pmid
    24331155
    relationship
    Comment in

Authors and identifiers

  1. name
    Butts C
    type
    Author
  2. name
    Socinski MA
    type
    Author
  3. name
    Mitchell PL
    type
    Author
  4. name
    Thatcher N
    type
    Author
  5. name
    Havel L
    type
    Author
  6. name
    Krzakowski M
    type
    Author
  7. name
    Nawrocki S
    type
    Author
  8. name
    Ciuleanu TE
    type
    Author
  9. name
    Bosquée L
    type
    Author
  10. name
    Trigo JM
    type
    Author
  11. name
    Spira A
    type
    Author
  12. name
    Tremblay L
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Butts C
    type
    Author
  2. name
    Socinski MA
    type
    Author
  3. name
    Mitchell PL
    type
    Author
  4. name
    Thatcher N
    type
    Author
  5. name
    Havel L
    type
    Author
  6. name
    Krzakowski M
    type
    Author
  7. name
    Nawrocki S
    type
    Author
  8. name
    Ciuleanu TE
    type
    Author
  9. name
    Bosquée L
    type
    Author
  10. name
    Trigo JM
    type
    Author
  11. name
    Spira A
    type
    Author
  12. name
    Tremblay L
    type
    Author
bibliography ids
  1. nci-bib-cadc04a6c64ba0db5ea3d4bb
book metadata
content sha256
1051053afba0e490ab977b9d52fa6b67b751c8c135d6122b3023e87288725e0a
document type
citation
dois
  1. 10.1016/S1470-2045(13)70510-2
electronic publication date
display
2013 Dec 9
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:24331154
immutable id
pubmed:24331154@1051053afba0e490ab977b9d52fa6b67b751c8c135d6122b3023e87288725e0a
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
1
name
The Lancet. Oncology
nlm unique id
100957246
pages
59-68
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Jan;15(1):5-6. doi: 10.1016/S1470-2045(13)70572-2.
    note
    Source null
    related pmid
    24331155
    relationship
    Comment in
outcomes validated
false
pmid
24331154
provenance
batch id
af10498814d931b53231
provider
NCBI PubMed ESummary
record sha256
d4265dbd26bb58d663e208d90e8f7007ff16edbc77e03bcb4c437bdc0e7dbca7
response sha256
077a09272afe77e74d5ff01cb33335ddb8a638b7afbafb70ec20e837a0c85c7f
retrieved at
2026-09-09T23:47:00.193465+00:00
publication date
display
2014 Jan
precision
month
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24331154/
title
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.

Preserved source evidence · Not medical advice